Menu
The MCA Blog - Connecting with others one story at a time

The Mesothelioma.com Blog

Connecting with others one story at a time

Categories
CATEGORY

Treatment

Yearly Recap: 2020 Mesothelioma Treatment Advances
Treatment

Yearly Recap: 2020 Mesothelioma Treatment Advances

January 7th, 2021 by
GATA3 Mesothelioma Biomarker
Treatment

Mesothelioma Survival in Men vs. Women With GATA3 Biomarker

December 17th, 2020 by
Tumor Treating Fields for Mesothelioma
Treatment

Tumor Treating Fields Become More Widely Available to Mesothelioma Patients

December 3rd, 2020 by
Phase 1 Clinical Trial for Mesothelioma Patients Gets FDA Approval
Treatment

FDA Approves New CAR T-Cell Therapy Phase 1 Clinical Trial for Mesothelioma Patients

October 29th, 2020 by
FDA Approves New Pleural Mesothelioma Treatment
Treatment

FDA Approves Immunotherapy Combination Treatment for Pleural Mesothelioma

October 7th, 2020 by
UV1 Cancer Vaccine May Treat Mesothelioma
Treatment

New Cancer Vaccine May Show Promise for Mesothelioma

October 1st, 2020 by
Ways to Manage Mesothelioma Symptoms
Treatment

Managing Mesothelioma Symptoms

August 20th, 2020 by
Study testing immunotherapy drugs to improve mesothelioma patient survival.
Treatment

Study Tests Pretreating Patients With Immunotherapy to Improve Survival

August 13th, 2020 by

Navigation

Our Mission

Mesothelioma.com is dedicated to providing the latest medical information on mesothelioma, spreading awareness about the dangers of asbestos exposure and providing victims with free resources.

En Español:
¿Qué es el cáncer de mesotelioma?

Our Standards

The Mesothelioma.com editorial team works hard to offer current, factual, expert reviewed information about mesothelioma cancer and the risks of asbestos exposure.

Editorial Guidelines | Disclaimer | Privacy Policy

Contact Us

Phone

1-800-336-0086

Office

35 Thorpe Avenue, Suite 101
Wallingford, CT 06492

Accreditations

Copyright © 2021 by Mesothelioma.com. All Rights Reserved. The information contained on this site is proprietary and protected. Any unauthorized or illegal use, copying or dissemination will be prosecuted to the fullest extent of the law.

Notice: This website and its content are sponsored by Early, Lucarelli, Sweeney, & Meisenkothen, LLC, a law firm specializing in asbestos injury litigation.
Attorney Advertising. Prior results do not predict a similar outcome. Please read our disclaimer for more information.

Page last modified on January 21, 2021.

×